APA (7th ed.) Citation

L, I., S, T., W, F., T, Y., T, I., T, N., . . . K, F. (2026). Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma. Clinical genitourinary cancer, 24(2), 102500. https://doi.org/10.1016/j.clgc.2025.102500

Chicago Style (17th ed.) Citation

L, Inoki, et al. "Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma." Clinical Genitourinary Cancer 24, no. 2 (2026): 102500. https://doi.org/10.1016/j.clgc.2025.102500.

MLA (9th ed.) Citation

L, Inoki, et al. "Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma." Clinical Genitourinary Cancer, vol. 24, no. 2, 2026, p. 102500, https://doi.org/10.1016/j.clgc.2025.102500.